These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15364965)

  • 1. Can we now agree to use the same definition to measure response according to CA-125?
    Rustin GJ
    J Clin Oncol; 2004 Oct; 22(20):4035-6. PubMed ID: 15364965
    [No Abstract]   [Full Text] [Related]  

  • 2. [CA 125 in epithelial ovarian cancer].
    Mogensen O
    Ugeskr Laeger; 1998 May; 160(22):3236. PubMed ID: 9621807
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ovarian cancer].
    Finnish Gynecological Association
    Duodecim; 2001; 117(22):2318-32. PubMed ID: 12183965
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of serum and tissular expression of CA 125 antigen, in evaluation of the response to second line chemotherapy for the relapsed ovarian carcinoma.
    Bădulescu F; Bădulescu A; Schenker M; Popescu CF; Stoica Z
    Rom J Morphol Embryol; 2005; 46(4):329-34. PubMed ID: 16688372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myth of measurable disease in ovarian cancer.
    Markman M
    J Clin Oncol; 2003 Aug; 21(16):3013-5. PubMed ID: 12915591
    [No Abstract]   [Full Text] [Related]  

  • 6. [Key problems to diagnosis and treatment of epithelial ovarian cancer].
    Shen K; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):65-8. PubMed ID: 12833894
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ovarian cancers and CA 125 in 2006].
    Lambaudie E; Collinet P; Vinatier D
    Gynecol Obstet Fertil; 2006 Mar; 34(3):254-7. PubMed ID: 16529967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?
    Gronlund B; Høgdall C; Hilden J; Engelholm SA; Høgdall EV; Hansen HH
    J Clin Oncol; 2004 Oct; 22(20):4051-8. PubMed ID: 15364966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of tuberculous peritonitis with elevated CA 125.
    Cakir M; Dilber E; Yariş N; Mungan I; Okten A
    Turk J Pediatr; 2005; 47(1):100-2. PubMed ID: 15884642
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).
    Taylor PT; Haverstick D
    J Natl Cancer Inst; 2005 Jan; 97(2):151; author reply 152. PubMed ID: 15657346
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ovarian carcinoma: certain characteristics of evolution, advancement and diagnosis].
    Prokopenko PG; Terent'ev AA
    Vopr Onkol; 2009; 55(2):143-50. PubMed ID: 19514366
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in the study of normal-sized ovary carcinoma syndrome].
    Zeng DY; Shen J
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1149-51. PubMed ID: 16029582
    [No Abstract]   [Full Text] [Related]  

  • 13. CA-125 and early ovarian cancer: does this help the clinician or further muddy the water?
    McGuire WP
    J Clin Oncol; 2005 Sep; 23(25):5862-4. PubMed ID: 16087955
    [No Abstract]   [Full Text] [Related]  

  • 14. Lights and shadows of the tumoral marker CA-125 in ovarian cancer.
    Sánchez Muñoz A; González Martín A; Mendiola Fernández C
    Clin Transl Oncol; 2008 Aug; 10(8):449-52. PubMed ID: 18667373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tumour markers in epithelial ovarian cancer].
    Sparholt MH; Høgdall E; Høgdall CK
    Ugeskr Laeger; 2009 Nov; 171(48):3505-9. PubMed ID: 19944049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA125 Nadir values as a prognostic factor in epithelial ovarian cancer.
    Altundag K; Altundag O; Morandi P; Gunduz M
    J Clin Oncol; 2005 Apr; 23(10):2435-6; author reply 2436. PubMed ID: 15800343
    [No Abstract]   [Full Text] [Related]  

  • 17. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
    Zheng Y; Katsaros D; Shan SJ; de la Longrais IR; Porpiglia M; Scorilas A; Kim NW; Wolfert RL; Simon I; Li L; Feng Z; Diamandis EP
    Clin Cancer Res; 2007 Dec; 13(23):6984-92. PubMed ID: 18056174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hemolytic anemia associated with ovarian cancer.
    Morris PG; Swords R; Sukor S; Fortune A; O'Donnell DM; Conneally E
    J Clin Oncol; 2008 Oct; 26(30):4993-5. PubMed ID: 18809611
    [No Abstract]   [Full Text] [Related]  

  • 20. Massive ascites as a presentation in a young woman with endometriosis: a case report.
    Sait KH
    Fertil Steril; 2008 Nov; 90(5):2015.e17-9. PubMed ID: 18778818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.